BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8336948)

  • 1. c-Myb and v-Myb are differentially phosphorylated by p42mapk in vitro.
    Aziz N; Wu J; Dubendorff JW; Lipsick JS; Sturgill TW; Bender TP
    Oncogene; 1993 Aug; 8(8):2259-65. PubMed ID: 8336948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of c-Myb-induced transcription activation by a phosphorylation site near the negative regulatory domain.
    Aziz N; Miglarese MR; Hendrickson RC; Shabanowitz J; Sturgill TW; Hunt DF; Bender TP
    Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6429-33. PubMed ID: 7604007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
    Mosialos G; Gilmore TD
    Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation by the carboxyl terminus of c-Myb depends upon both the Myb DNA-binding domain and the DNA recognition site.
    Dubendorff JW; Lipsick JS
    Oncogene; 1999 Jun; 18(23):3452-60. PubMed ID: 10376523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The carboxy-terminal domain of c-Myb activates reporter gene expression in yeast.
    Seneca S; Punyammalee B; Sureau A; Perbal B; Dvorák M; Crabeel M
    Oncogene; 1993 Sep; 8(9):2335-42. PubMed ID: 8361752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. tom-1, a novel v-Myb target gene expressed in AMV- and E26-transformed myelomonocytic cells.
    Burk O; Worpenberg S; Haenig B; Klempnauer KH
    EMBO J; 1997 Mar; 16(6):1371-80. PubMed ID: 9135152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The myb oncogene.
    Lipsick JS; Baluda MA
    Gene Amplif Anal; 1986; 4():73-98. PubMed ID: 3333362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation-sensitive DNA binding by v-myb and c-myb proteins.
    Klempnauer KH
    Oncogene; 1993 Jan; 8(1):111-5. PubMed ID: 8423989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation.
    Lüscher B; Christenson E; Litchfield DW; Krebs EG; Eisenman RN
    Nature; 1990 Apr; 344(6266):517-22. PubMed ID: 2157164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation by v-Myb.
    Lipsick JS; Wang DM
    Oncogene; 1999 May; 18(19):3047-55. PubMed ID: 10378700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The various domains of v-myb and v-ets oncogenes of E26 retrovirus contribute differently, but cooperatively, in transformation of hematopoietic lineages.
    Domenget C; Leprince D; Pain B; Peyrol S; Li RP; Stehelin D; Samarut J; Jurdic P
    Oncogene; 1992 Nov; 7(11):2231-41. PubMed ID: 1331935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transactivation and on the cooperativity with NF-M.
    Oelgeschläger M; Janknecht R; Krieg J; Schreek S; Lüscher B
    EMBO J; 1996 Jun; 15(11):2771-80. PubMed ID: 8654374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domain.
    Hu YL; Ramsay RG; Kanei-Ishii C; Ishii S; Gonda TJ
    Oncogene; 1991 Sep; 6(9):1549-53. PubMed ID: 1923521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of c-Myb through protein phosphorylation and leucine zipper interactions.
    Ramsay RG; Morrice N; Van Eeden P; Kanagasundaram V; Nomura T; De Blaquiere J; Ishii S; Wettenhall R
    Oncogene; 1995 Nov; 11(10):2113-20. PubMed ID: 7478531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming potential of truncated v-myb and stimulation of replication by gag-myb fusion products.
    Merzak A; Soret J; Martinerie C; Sureau A; Crochet J; Perbal B
    Oncogene; 1992 Mar; 7(3):535-42. PubMed ID: 1549366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single amino-acid substitution in the DNA-binding domain of the myb oncogene confers a thermolabile phenotype to E26-transformed myeloid cells.
    Li RP; Duterque-Coquillaud M; Lagrou C; Debuire B; Graf T; Stehelin D; Leprince D
    Oncogene Res; 1989; 5(2):137-41. PubMed ID: 2608278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural analysis of normal and transforming mil(raf) proteins: effect of 5'-truncation on phosphorylation in vivo or in vitro.
    Patschinsky T; Bister K
    Oncogene; 1988 Oct; 3(4):357-64. PubMed ID: 3274084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIPK1 interacts with c-Myb and modulates its activity through phosphorylation.
    Matre V; Nordgård O; Alm-Kristiansen AH; Ledsaak M; Gabrielsen OS
    Biochem Biophys Res Commun; 2009 Oct; 388(1):150-4. PubMed ID: 19646965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. V-myb oncogene and c-myb proto-oncogene expression in avian cells: morphological changes of the cells and topographic localization of myb proteins.
    Korb J; Stokrová J; Karafiát V; Dvoráková M; Cermáková V
    Acta Virol; 1996 Apr; 40(2):81-6. PubMed ID: 8886116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK.
    Kanei-Ishii C; Ninomiya-Tsuji J; Tanikawa J; Nomura T; Ishitani T; Kishida S; Kokura K; Kurahashi T; Ichikawa-Iwata E; Kim Y; Matsumoto K; Ishii S
    Genes Dev; 2004 Apr; 18(7):816-29. PubMed ID: 15082531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.